Thioredoxin as a putative biomarker and candidate target in age-related immune decline

Helen R. Griffiths, Stuart J. Bennett, Peter Olofsson, Christopher R. Dunston

Research output: Contribution to journalArticle

Abstract

The oxidoreductase Trx-1 (thioredoxin 1) is highly conserved and found intra- and extra-cellularly in mammalian systems. There is increasing interest in its capacity to regulate immune function based on observations of altered distribution and expression during ageing and disease. We have investigated previously whether extracellular T-cell or peripheral blood mononuclear cell Trx-1 levels serve as a robust marker of ageing. In a preliminary study of healthy older adults compared with younger adults, we showed that therewas a significant, butweak, relationshipwith age. Interestingly, patientswith rheumatoid arthritis and cancer have been described by others to secrete or express greater surface Trx-1 than predicted. It is interesting to speculate whether a decline in Trx-1 during ageing protects against such conditions, but correspondingly increases risk of disease associated with Trx-1 depletion such as cardiovascular disease. These hypotheses are being explored in the MARK-AGE study, and preliminary findings confirm an inverse correlation of surface Trx-1 with age. We review recent concepts around the role of Trx-1 and its partners in T-cell function on the cell surface and as an extracellular regulator of redox state in a secreted form. Further studies on the redox state and binding partners of surface and secreted Trx-1 in larger patient datasets are needed to improve our understanding of why Trx-1 is important for lifespan and immune function. © The Authors Journal compilation © 2014 Biochemical Society.

Original languageEnglish
Pages (from-to)922-927
Number of pages6
JournalBiochemical Society Transactions
Volume42
Issue number4
DOIs
Publication statusPublished - 31 Aug 2014

Fingerprint

Thioredoxins
Biomarkers
T-cells
Aging of materials
Oxidation-Reduction
T-Lymphocytes
Young Adult
Blood Cells
Rheumatoid Arthritis
Oxidoreductases
Blood
Cardiovascular Diseases

Keywords

  • ageing
  • oxidation
  • reactive oxygen species (ROS)
  • rheumatoid arthritis
  • thiol
  • thioredoxin

Cite this

Griffiths, Helen R. ; Bennett, Stuart J. ; Olofsson, Peter ; Dunston, Christopher R. / Thioredoxin as a putative biomarker and candidate target in age-related immune decline. In: Biochemical Society Transactions. 2014 ; Vol. 42, No. 4. pp. 922-927.
@article{067ce63c8b1a42f19e9c425443fb0143,
title = "Thioredoxin as a putative biomarker and candidate target in age-related immune decline",
abstract = "The oxidoreductase Trx-1 (thioredoxin 1) is highly conserved and found intra- and extra-cellularly in mammalian systems. There is increasing interest in its capacity to regulate immune function based on observations of altered distribution and expression during ageing and disease. We have investigated previously whether extracellular T-cell or peripheral blood mononuclear cell Trx-1 levels serve as a robust marker of ageing. In a preliminary study of healthy older adults compared with younger adults, we showed that therewas a significant, butweak, relationshipwith age. Interestingly, patientswith rheumatoid arthritis and cancer have been described by others to secrete or express greater surface Trx-1 than predicted. It is interesting to speculate whether a decline in Trx-1 during ageing protects against such conditions, but correspondingly increases risk of disease associated with Trx-1 depletion such as cardiovascular disease. These hypotheses are being explored in the MARK-AGE study, and preliminary findings confirm an inverse correlation of surface Trx-1 with age. We review recent concepts around the role of Trx-1 and its partners in T-cell function on the cell surface and as an extracellular regulator of redox state in a secreted form. Further studies on the redox state and binding partners of surface and secreted Trx-1 in larger patient datasets are needed to improve our understanding of why Trx-1 is important for lifespan and immune function. {\circledC} The Authors Journal compilation {\circledC} 2014 Biochemical Society.",
keywords = "ageing, oxidation, reactive oxygen species (ROS), rheumatoid arthritis, thiol, thioredoxin",
author = "Griffiths, {Helen R.} and Bennett, {Stuart J.} and Peter Olofsson and Dunston, {Christopher R.}",
year = "2014",
month = "8",
day = "31",
doi = "10.1042/BST20140162",
language = "English",
volume = "42",
pages = "922--927",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "4",

}

Thioredoxin as a putative biomarker and candidate target in age-related immune decline. / Griffiths, Helen R.; Bennett, Stuart J.; Olofsson, Peter; Dunston, Christopher R.

In: Biochemical Society Transactions, Vol. 42, No. 4, 31.08.2014, p. 922-927.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Thioredoxin as a putative biomarker and candidate target in age-related immune decline

AU - Griffiths, Helen R.

AU - Bennett, Stuart J.

AU - Olofsson, Peter

AU - Dunston, Christopher R.

PY - 2014/8/31

Y1 - 2014/8/31

N2 - The oxidoreductase Trx-1 (thioredoxin 1) is highly conserved and found intra- and extra-cellularly in mammalian systems. There is increasing interest in its capacity to regulate immune function based on observations of altered distribution and expression during ageing and disease. We have investigated previously whether extracellular T-cell or peripheral blood mononuclear cell Trx-1 levels serve as a robust marker of ageing. In a preliminary study of healthy older adults compared with younger adults, we showed that therewas a significant, butweak, relationshipwith age. Interestingly, patientswith rheumatoid arthritis and cancer have been described by others to secrete or express greater surface Trx-1 than predicted. It is interesting to speculate whether a decline in Trx-1 during ageing protects against such conditions, but correspondingly increases risk of disease associated with Trx-1 depletion such as cardiovascular disease. These hypotheses are being explored in the MARK-AGE study, and preliminary findings confirm an inverse correlation of surface Trx-1 with age. We review recent concepts around the role of Trx-1 and its partners in T-cell function on the cell surface and as an extracellular regulator of redox state in a secreted form. Further studies on the redox state and binding partners of surface and secreted Trx-1 in larger patient datasets are needed to improve our understanding of why Trx-1 is important for lifespan and immune function. © The Authors Journal compilation © 2014 Biochemical Society.

AB - The oxidoreductase Trx-1 (thioredoxin 1) is highly conserved and found intra- and extra-cellularly in mammalian systems. There is increasing interest in its capacity to regulate immune function based on observations of altered distribution and expression during ageing and disease. We have investigated previously whether extracellular T-cell or peripheral blood mononuclear cell Trx-1 levels serve as a robust marker of ageing. In a preliminary study of healthy older adults compared with younger adults, we showed that therewas a significant, butweak, relationshipwith age. Interestingly, patientswith rheumatoid arthritis and cancer have been described by others to secrete or express greater surface Trx-1 than predicted. It is interesting to speculate whether a decline in Trx-1 during ageing protects against such conditions, but correspondingly increases risk of disease associated with Trx-1 depletion such as cardiovascular disease. These hypotheses are being explored in the MARK-AGE study, and preliminary findings confirm an inverse correlation of surface Trx-1 with age. We review recent concepts around the role of Trx-1 and its partners in T-cell function on the cell surface and as an extracellular regulator of redox state in a secreted form. Further studies on the redox state and binding partners of surface and secreted Trx-1 in larger patient datasets are needed to improve our understanding of why Trx-1 is important for lifespan and immune function. © The Authors Journal compilation © 2014 Biochemical Society.

KW - ageing

KW - oxidation

KW - reactive oxygen species (ROS)

KW - rheumatoid arthritis

KW - thiol

KW - thioredoxin

UR - http://www.scopus.com/inward/record.url?scp=84905866456&partnerID=8YFLogxK

U2 - 10.1042/BST20140162

DO - 10.1042/BST20140162

M3 - Article

VL - 42

SP - 922

EP - 927

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 4

ER -